ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BGLC BioNexus Gene Lab Corporation

0.50
0.021 (4.38%)
Jun 15 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 131,294
Bid Price 0.43
Ask Price 0.80
News -
Day High 0.45

Low
0.31

52 Week Range

High
9.49

Day Low 0.4311
Company Name Stock Ticker Symbol Market Type
BioNexus Gene Lab Corporation BGLC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.021 4.38% 0.50 00:00:08
Open Price Low Price High Price Close Price Prev Close
0.45 0.4311 0.45 0.442 0.479
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
198 131,294 $ 0.4479673 $ 58,815 - 0.31 - 9.49
Last Trade Time Type Quantity Stock Price Currency
19:59:56 formt 500 $ 0.50 USD

BioNexus Gene Lab Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.77M 17.67M - 10.26M -2.63M -0.15 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioNexus Gene Lab News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BGLC Message Board. Create One! See More Posts on BGLC Message Board See More Message Board Posts

Historical BGLC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.5780.630.43110.513862794,021-0.078-13.49%
1 Month0.560.750.42020.5142649339,959-0.06-10.71%
3 Months0.731.000.42020.6223111231,629-0.23-31.51%
6 Months0.663.390.40041.34853,334-0.16-24.24%
1 Year3.509.490.311.481,800,394-3.00-85.71%
3 Years3.509.490.311.481,800,394-3.00-85.71%
5 Years3.509.490.311.481,800,394-3.00-85.71%

BioNexus Gene Lab Description

BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.

Your Recent History

Delayed Upgrade Clock